2005China Public HealthRequires access

Relationship between antimicrobial susceptibility and highly active β-lactamases in Pseudomonas aeruginosa

Wen Jingyun

Open publisher page 0 citations

Abstract

Objective To investigate the antimicrobial resistance and the prevanlence of production of AmpC β-lactamases,extended-spectrum β-lactamases(ESBLs)and metallo β-lactamases(MBLs)in Pseudomonas aeruginosa(P.aeruginosa)clinical isolates,for guiding the rational use of antibiotics. Methods Antimicrobial susceptibility tests were done by Kirby-Bauer disk diffusions method,the phenotypes of P.aeruginosa strains harboring AmpC β-lactamases and /or ESBLs were detected by modified three-dimensional extract test,while MBLs were identified using MBL E-test strips. Results The susceptibility rate of 186 P.aeruginosa clinical isolates to imipenem was the highest about 82.3%,as to ciprofloxacin,piperacillin/tazobactam,ceftazidime,amikacin,cefoperazone/sulbactam were 75.3%,74.2%,72.6%,71.0%,70.4% respectively,but to ticarcillin,cefoperazone,aztreonam were no more than 60%.The resistant rates to cefotaxime and ceftriaxone were 61.8% and 55.9% respectively.AmpC β-lactamases,Amcp β-lactamases combined with ESBLs,ESBLs and MBLs producing strains were detected in 8.6%,2.7%,14.5% and 4.8% of P.aeruginosa respectively. Conclusion The resistant phenomenon of P.aeruginosa clinical isolates should not be ignored,production of highly active β-lactamases is one of resistant mechanisms in P.aeruginosa,imipenem is still the best choice for treating infection caused by P.aeruginosa.

About this research paper

What this paper is about

Objective To investigate the antimicrobial resistance and the prevanlence of production of AmpC β-lactamases,extended-spectrum β-lactamases(ESBLs)and metallo β-lactamases(MBLs)in Pseudomonas aeruginosa(P.aeruginosa)clinical isolates,for guiding the rational use of antibiotics. Methods Antimicrobial susceptibility tests were done by Kirby-Bauer disk diffusions method,the phenotypes of P.aeruginosa strains harboring AmpC β-lactamases and /or ESBLs were detected by modified three-dimensional extract test,while MBLs were identified using MBL E-test strips. Results The susceptibility rate of 186 P.aeruginosa clinical isolates to imipenem was the highest about 82.3%,as to ciprofloxacin,piperacillin/tazobactam,ceftazidime,amikacin,cefoperazone/sulbactam were 75.3%,74.2%,72.6%,71.0%,70.4% respectively,but to ticarcillin,cefoperazone,aztreonam were no more than 60%.The resistant rates to cefotaxime and ceftriaxone were 61.8% and 55.9% respectively.AmpC β-lactamases,Amcp β-lactamases combined with ESBLs,ESBLs and MBLs producing strains were detected in 8.6%,2.7%,14.5% and 4.8% of P.aeruginosa respectively. Conclusion The resistant phenomenon of P.aeruginosa clinical isolates should not be ignored,production of highly active β-lactamases is one of resistant mechanisms in P.aeruginosa,imipenem is still the best choice for treating infection caused by P.aeruginosa.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the antimicrobial resistance and the prevanlence of production of AmpC β-lactamases,extended-spectrum β-lactamases(ESBLs)and metallo β-lactamases(MBLs)in Pseudomonas aeruginosa(P.aeruginosa)clinical isolates,for guiding the rational use of antibiotics. Methods Antimicrobial susceptibility tests were done by Kirby-Bauer disk diffusions method,the phenotypes of P.aeruginosa strains harboring AmpC β-lactamases and /or ESBLs were detected by modified three-dimensional extract test,while MBLs were identified using MBL E-test strips. Results The susceptibility rate of 186 P.aeruginosa clinical isolates to imipenem was the highest about 82.3%,as to ciprofloxacin,piperacillin/tazobactam,ceftazidime,amikacin,cefoperazone/sulbactam were 75.3%,74.2%,72.6%,71.0%,70.4% respectively,but to ticarcillin,cefoperazone,aztreonam were no more than 60%.The resistant rates to cefotaxime and ceftriaxone were 61.8% and 55.9% respectively.AmpC β-lactamases,Amcp β-lactamases combined with ESBLs,ESBLs and MBLs producing strains were detected in 8.6%,2.7%,14.5% and 4.8% of P.aeruginosa respectively. Conclusion The resistant phenomenon of P.aeruginosa clinical isolates should not be ignored,production of highly active β-lactamases is one of resistant mechanisms in P.aeruginosa,imipenem is still the best choice for treating infection caused by P.aeruginosa.

Key concepts: Cefoperazone, Aztreonam, Ticarcillin, Pseudomonas aeruginosa, Microbiology, Piperacillin, Imipenem, Sulbactam

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship between antimicrobial susceptibility and highly active β-lactamases in Pseudomonas aeruginosa — Research Paper | ScholarLens